148 related articles for article (PubMed ID: 11399689)
1. Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment.
Giannini D; Di Franco A; Bacci E; Dente FL; Bartoli ML; Vagaggini B; Paggiaro P
Chest; 2001 Jun; 119(6):1671-5. PubMed ID: 11399689
[TBL] [Abstract][Full Text] [Related]
2. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to the protective effect of salmeterol in mild untreated asthmatics.
Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Taccola M; Tonelli M; Zingoni M; Paggiaro P
Pulm Pharmacol Ther; 2003; 16(6):355-60. PubMed ID: 14580927
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL
Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060
[TBL] [Abstract][Full Text] [Related]
5. Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge.
Paggiaro PL; Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Tonelli M; Zingoni M
Pulm Pharmacol Ther; 2006; 19(6):425-9. PubMed ID: 16326121
[TBL] [Abstract][Full Text] [Related]
6. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
8. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
Simons FE; Gerstner TV; Cheang MS
Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
[TBL] [Abstract][Full Text] [Related]
11. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
Bhagat R; Kalra S; Swystun VA; Cockcroft DW
Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
14. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
15. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL
Pulm Pharmacol Ther; 2004; 17(3):147-53. PubMed ID: 15123224
[TBL] [Abstract][Full Text] [Related]
16. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
[TBL] [Abstract][Full Text] [Related]
17. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
20. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]